Article
05 Aug 2021
Ushering In A New Era: FDA Approves First Interchangeable Biosimilar
AUTHORS CONTENT
Article
14 Jun 2021
HHS Issues Buprenorphine Practice Guidelines As Study Confirms Access Barriers
Article
07 May 2021
FDA Ups The Ante And Sends First Notice Of Noncompliance For Failure To Submit Clinical Trial Results
Article
29 Mar 2021
CBD Regulatory Enforcement Continues With Over-the-Counter CBD Pain Relief Products
Article
10 Feb 2021
Working Together, FDA, NTIA, And Domain Registries Take Down 30 Websites Illegally Selling Opioids
Article
29 Jan 2021
Recent Amendments To The FDA Laws Attempt To Clarify And Improve Existing Systems
Article
26 Nov 2020
Are Speaker Programs A Thing Of The Past? OIG's Fraud Alert Indicates It Thinks They Should Be
Article
14 Nov 2020
DEA Releases Long-Awaited Suspicious Orders Proposed Rule
Video
04 Sep 2020
Introduction To The Due Diligence Process, Second Edition (Video)
Article
25 Aug 2020
OTC Monograph Reform: Key Takeaways And What Industry Can Expect